Baseline Variable | n (%) |
---|---|
Sex | |
Women | 23 (92) |
Men | 2 (8) |
Race/ethnicity | |
Non-Hispanic black | 9 (36) |
Non-Hispanic white | 10 (40) |
Hispanic | 6 (24) |
Insurance type | |
Medicaid | 8 (32) |
Medicare | 3 (12) |
Commercial | 13 (52) |
ADAP | 1 (4) |
Referral source | |
Internal | 11 (44) |
Academic center | 8 (32) |
Private practice | 6 (24) |
Baseline labs (median [range]) | |
CD4 count (cells/mm2) | 114 (6–524) |
Viral load (copies/mL) | 54, 581 (<50–670, 000) |
Referral source | |
Internal | 11 (44) |
Academic center | 8 (32) |
Private practice | 6 (24) |
Eligibility criteria | |
Resistance | 24 (96) |
Intolerance | 1 (4) |
Study medications | |
ETV | 1 (4) |
RAL | 4 (16) |
ETV/RAL | 19 (76) |
ETV/RAL/MVC | 1 (4) |
ADAP, New York State AIDS Drug Assistance Program; ETV, etravirine; RAL, raltegravir; MVC, maraviroc.